Paysign (PAYS) Q2 FY26 earnings call

Paysign delivered a record-setting second quarter, driven by robust growth in its patient affordability segment and a recovery in the plasma business. The company raised its full-year outlook, reflecting strong program momentum and expanding margins, with a strategic focus on scaling its high-margin patient affordability platform while leveraging its cash-generative plasma core.